Effectiveness of a computer-facilitated intervention on improving provider delivery of tobacco treatment in a thoracic surgery and oncology outpatient setting: A pilot study.

Autor:	Nayak MM; Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, Boston, United States.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, United States., Mazzola E; Department of Data Science, Dana-Farber Cancer Institute, Boston, United States., Jaklitsch MT; Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, United States., Drehmer JE; Division of General Academic Pediatrics, Massachusetts General Hospital for Children, Boston, United States.; Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston, United States., Nabi-Burza E; Division of General Academic Pediatrics, Massachusetts General Hospital for Children, Boston, United States.; Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston, United States., Bueno R; Division of Thoracic Surgery, Brigham and Women's Hospital, Boston, United States., Winickoff JP; Division of General Academic Pediatrics, Massachusetts General Hospital for Children, Boston, United States.; Tobacco Research and Treatment Center, Massachusetts General Hospital, Boston, United States., Cooley ME; Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, Boston, United States.
Jazyk:	angličtina
Zdroj:	Tobacco induced diseases [Tob Induc Dis] 2024 Apr 22; Vol. 22. Date of Electronic Publication: 2024 Apr 22 (Print Publication: 2024).
DOI:	10.18332/tid/186272
Abstrakt:	Introduction: Effective tobacco treatments are available but are often not delivered to individuals with an actual or potential diagnosis of thoracic malignancy. The specific aims of this study were to identify the prevalence of tobacco use and examine the effectiveness of the Clinical and community Effort Against Smoking and secondhand smoke Exposure (CEASE), a system-level computer-facilitated intervention, to improve provider delivery of tobacco treatment in a thoracic surgery and oncology outpatient setting. Methods: A pre-post-test design was used to assess the effectiveness of CEASE. A 3-step approach was used to integrate tobacco treatment into routine care: ask about tobacco use, assist with cessation, and refer to a quitline. An end-of-visit survey was conducted to collect prevalence of tobacco use and delivery of tobacco treatment. Descriptive statistics and Fisher's exact test were used for analysis. Results: A total of 218 individuals were enrolled; 105 participants were in usual care (UC) and 113 were in the CEASE group. Of those who enrolled, 27.6% were never smokers in UC and 27.7% in CEASE, 60% were former smokers in UC and 50% in CEASE, and 12.4% were current smokers in UC and 21.4% in CEASE. Significant differences were noted in delivery of tobacco treatment with 15.4% having received tobacco treatment in UC compared to 62.5% in CEASE (p<0.004). Conclusions: A computer-facilitated intervention increased provider delivery of tobacco treatment in a thoracic surgery and oncology outpatient setting. This intervention provided a low-resource approach that has the potential to be scaled and implemented more broadly. Competing Interests: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. The authors declare that they have no competing interests, financial or otherwise, related to the current work. All the authors report that since the initial planning of the work they received support from Dana-Farber/Harvard Cancer Center (Grant P30CA006516, PI: Edward Benz). E. Mazzola reports that in the past 36 months she has received payments from the Brown University for her lectures on regression trees, which are not relevant to the present study. Also, R. Bueno reports that in the past 36 months he has received grants from Verastem, Genetech, Roche, Myriad Genetics, Novartis, Siemens, Gritstone, Epizyme, MedGenome, Merck, Bicycle Therapeutics, Bayer, Intuitive Surgical, Northpond, NCI, NIH, DoD, NIBIB, and NHLBI. He also reports that he received consulting fees from Regeneron, Covidien/Medtronic, and DiNAQOR, and payments for expert testimony from the Public Health Advocacy Institute, Thornton Law Firm LLP, Blankingship & Keith PC, MRHFM Law LLC, Carpenter, Zuckerman & Rowley, Phillips & Paolicelli LLP, and Foster & Eldridge LLP. Finally, R. Bueno reports that he has patents licensed to BWH through Navigation Sciences. J.P. Winickoff reports that in the past 36 months he has served as a paid expert witness in litigation against the tobacco industry. Also, M.M. Nayak and M.E. Cooley report that in the past 36 months they received a National Comprehensive Cancer Center/Astra Zeneca grant to improve outcomes in early-stage NSCLC (Cooley and Healey, co-PIs). (© 2024 Nayak M.M. et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu PDF